Skip to main content
Premium Trial:

Request an Annual Quote

Generation Health Contracts with PGXL to Offer Pharmacogenetic Tests

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Generation Health has contracted with PGXL Laboratories to be a preferred genetic testing lab providing molecular diagnostic test services for Generation Health.

In a pilot program starting next month, the partners will provide pharmacogenetic testing and diagnostic services to a limited number of patients through healthcare providers. In January 2011, those services will be opened up to all GH patients, Brad Esarey, director of sales and marketing for PGXL, said.

Terms of the agreement were not disclosed.

Based in Louisville, KY., PGXL is a molecular diagnostics lab. According to PGXL, it was the first laboratory in the country specifically CLIA certified to provide pharmacogenetic tests. Generation Health is a genetic benefit management company based in Upper Saddle River, NJ, partially owned by pharmacy services and benefit management firm CVS Caremark.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.